Using antibodies isolated from glomeruli of nephritic rats we have previously identified a 330-kDa cell surface glycoprotein (gp330) as a major pathogenic antigen of Heymann nephritis (HN), an experimental model of human membranous glomerulonephritis. Recently, we have isolated a cDNA clone, C14, encoding a polypeptide that contains a pathogenic epitope of HN responsible for the initiation of the disease. Subsequently, another protein, a2-macroglobulin receptor-associated protein (a2-MRAP), which is a subunit of the receptor for human a2-macroglobulin/low density lipoprotein receptor-related protein (LRP), was shown to possess a high degree of sequence homology to the C14 protein (C14p). In this report, we have investigated the relationship between gp330, C14p, and ei-MRAP. Immunoprecipitation studies demonstrate that gp330 forms a heterodimeric aciation with a 444kDa polypeptide that is stable to detergent extraction and long-term centrifugation. Further, immunoblotting analysis on the purified complex indicates that the 44-kDa associated protein shares immunological identity to C14p and a2-MRAP. In addition, antibodies eluted from glomeruli of HN rats and antibodies to a C14 fusion protein immunoprecipitated gp330 and the 44-kDa protein, demonstrating that the epitopes responsible for the initial events of HN are accessible within the complex. Based on these data, three models are proposed to explain how pathogenic epitopes in the gp330-44-kDa, HN antigenic complex may be presented at the cell surface and initiate the onset of HN.
the purified complex indicates that the 44-kDa associated protein shares immunological identity to C14p and a2-MRAP. In addition, antibodies eluted from glomeruli of HN rats and antibodies to a C14 fusion protein immunoprecipitated gp330 and the 44-kDa protein, demonstrating that the epitopes responsible for the initial events of HN are accessible within the complex. Based on these data, three models are proposed to explain how pathogenic epitopes in the gp330-44-kDa, HN antigenic complex may be presented at the cell surface and initiate the onset of HN.
Heymann nephritis (HN) is an autoimmune disorder that provides an animal model for the study of human membranous glomerulonephritis (1, 2) . The disease is initiated by the binding of circulating antibodies to glomeruli (3, 4) , where they interact with antigens at the surface of the glomerular epithelium (5, 6) . The resultant immune complexes are then shed and crosslinked to the basement membrane, resulting in severe glomerular injury and proteinuria (7) . Antibodies eluted from the glomeruli of HN rats demonstrate specificity for gp330, a large membrane-associated glycoprotein (5) . gp330 is localized in coated pits found in the proximal tubule brush border and at the base of the foot processes of glomerular podocytes (6) . The mechanism that initiates immune complex deposition is not understood but has been thought to involve the presentation of pathogenic epitopes present within gp330 (7, 8) . Using antibodies eluted from the glomeruli of HN rats, Pietromonaco et al. (9) identified a cDNA, clone 14 (C14), encoding an -35-kDa protein that contains a major pathogenic domain of the HN antigen. Two other proteins-human a2-macroglobulin receptor-associated protein (a2-MRAP) (10) and a mouse heparin binding protein (HBP-44) (11)-were subsequently shown to possess a high degree of homology to the predicted amino acid sequence of the C14 cDNA. In this report, we show that gp330 forms a stable heterodimeric complex with a 44-kDa polypeptide that demonstrates immunoreactivity with antibodies to the C14 protein (C14p) and a2-MRAP.
MATERIALS AND METHODS
Antibodies. Polyclonal antisera to gp330 and C14/pgalactosidase fusion protein were prepared as described (6, 9) . Antiserum to rat a2-MRAP/glutathione transferase fusion protein was a generous gift from Joachim Herz (University of Texas Southwestern Medical Center, Dallas, TX). Antigp330 monoclonal antibody (mAb) 20B was prepared against a Triton X-114 extract ofglomerular cell membranes (12) , and mAb D1-55F21 was raised against purified gp330 (6) .
Kidney Microvilli. Microvillar membranes were prepared as described (6) and stored in liquid nitrogen.
Protein lodinations. lodinations were performed using the lodo-Gen method (Pierce) (13) . Labeled protein was separated from free 125I on a PD-10 column (Pharmacia) preequilibrated with phosphate-buffered saline (PBS) containing 0.1% Triton X-100. Specific activities for all iodinations were routinely 20,000-50,000 cpm/ng of protein.
Immunoprecipitations. Polyclonal antisera or ascites fluid (diluted 1:200) was preincubated with protein A-agarose (Bio-Rad) or goat anti-mouse agarose (Sigma), respectively, for 2 hr at 23°C. The beads were washed twice with PTO (PBS/0.5% Tween 20/5 mg of ovalbumin per ml) and incubated with radioiodinated brush border extract (107 cpm) for 16 hr at 4°C. They were then washed twice with RIPA buffer (10 mM Tris, pH 7.2/150 mM NaCI/1% deoxycholate/1% Triton X-100/0.1% sodium dodecyl sulfate/1% aprotinin/2 mM phenylmethanesulfonyl fluoride), twice with PTO, and twice with PT (PBS/0.5% Tween 20) . Laemmli sample buffer was added to the beads with 2% 2-mercaptoethanol (Bio-Rad) and boiled for 5 min. Immunoprecipitates were separated by SDS/PAGE on 5-12% gradient gels.
Affinity Purification of gp330. IgG was purified from 20B ascites fluid and coupled to Affi-Gel 10 beads (Bio-Rad). Kidney microvillar extract was diluted 10-fold with 20 mM Hepes, pH 7.4/150 mM NaCl/2 mM CaCl2/1% Triton X-100 and recirculated over the 20B affinity column for 16 hr at 4°C. The column was washed with 20 column volumes of dilution buffer and eluted with 10 mM sodium acetate, pH 3.0/5 mM EDTA/1% Triton X-100 into 1-ml fractions. 
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Triton X-100, and concentrated with Aquacide II (Calbiochem). Protein concentration was determined by the bicinchoninic acid assay (Pierce).
Oligomerization Assay. The oligomerization assay was performed on newborn rat kidneys biosynthetically labeled as described (unpublished work). Briefly, kidneys were removed from 1-to 2-day-old rats, injected with RPMI medium (Irvine Scientific) containing 3 mg of collagenase per ml (Worthington), and gassed with 95% 02/5% CO2. The tissue was manually dissociated with forceps, passed through a Pasteur pipette 20 times, washed in methionine-free RPMI medium, and incubated with 500 ,tCi of Tran35S-label (ICN; 1 Ci = 35 GBq) for 3 hr at 370C with constant gassing. The tissue was washed in ice-cold TBS (50 mM Tris, pH 7.4/150 mM NaCl/1 mM disopropyl fluorophosphate), disrupted with a Dounce homogenizer. The resulting homogenate was centrifuged at 750 x g for 10 min, after which the supernatant was centrifuged at 100,000 x g for 1 hr at 40C. The pellet was resuspended in lysis buffer (20 mM Mes/30 mM Tris, pH 7.4/150 mM NaCl/1% Triton X-100).
Velocity gradient centrifugation was performed as described (14) . Briefly, insoluble material was removed by centrifugation at 15,000 x g for 15 min at 4°C. The supernatant was overlaid onto a linear 5-25% sucrose gradient and centrifuged at 40,000 rpm for 4 hr at 4°C in a Beckman SW41 rotor. Fractions were collected and immunoprecipitates were prepared using 20B ascites fluid (1 hr at room temperature) and a rabbit anti-mouse IgG bridge (1 hr) prior to addition of protein A beads. Sedimentation coefficients were calculated using protein standards, and sucrose density was determined from the refractive index.
Electrophoresis and Immunoblotting. Proteins were separated by SDS/PAGE (15) . For immunoblotting, proteins were transferred to Immobilon (Millipore) using a semi-dry blotting apparatus (Millipore). Blots were blocked for 16 hr at 4°C with 50 mM Tris, pH 7.4/150 mM NaCl/3% bovine serum albumin (Sigma), followed by a 2-hr incubation at room temperature with the indicated antiserum. They were then washed 10 min each as follows: twice with 50 mM Tris, pH 7.4/150 mM NaCl (Tris/NaCI), twice with Tris/NaCl plus 0.05% Nonidet P-40, twice with Tris/NaCl. The Immobilon membranes were incubated for 1.5 hr at 23°C with 1 x 105 cpm of 125I-labeled protein G per ml (Sigma) diluted into blocking buffer, washed as described above, dried, and exposed to x-ray film at -70°C.
Immunocytochemistry. For immunofluorescence acetonedipped cryostat sections of unfixed kidney and semithin (2 ,um) cryosections of periodate/lysine/paraformaldehyde (PLP)-fixed kidney, prepared as described (16), were incubated with rabbit anti-C14p IgG (10 ,ug/ml) followed by incubation with rhodamine-conjugated anti-rabbit F(ab')2 (diluted 1:100) (Tago). For immunoelectron microscopy, sections of PLP-fixed kidneys were incubated in anti-C14p IgG followed by peroxidase-conjugated goat anti-rabbit Fab (Biosys) and processed for immunoperoxidase (6, 7) .
RESULTS gp330
Associates with a 44-kDa Polypeptide in Kidney Brush Border. Immunocytochemical and immunoblotting data indicate that gp330 is an abundant protein in the brush border of rat kidney proximal tubule (6, 16) . To facilitate biochemical characterization of gp330, microvillar fractions were prepared from perfused rat kidneys to enrich for membrane proteins associated with the brush border (Fig. 1, lane B) . The membranes were solubilized in 1% Triton X-100, radioiodinated, and immunoprecipitated using a gp330-specific polyclonal antibody (6) . (5) . To exclude the possibility of cross-reactivity of the polyclonal antisera with the 450-and 44-kDa species, immunoprecipitations were performed with two previously characterized mAbs, 20B and D1-55F21, specific for gp330 (6, 12 (9) . Both antibodies precipitated the 450-and 44-kDa polypeptides under nondenaturing conditions (Fig. 1, lanes F and G) . The larger protein was previously shown to be gp330 by immunoprecipitation (5, 6, 16) and Western blot analysis (17) . These results suggest that the HN antigen is a dimer consisting of gp330 and an associated 44-kDa subunit.
The antibodies eluted from the glomeruli of HN rats immunoprecipitated both subunits from Triton X-100-solubilized radioiodinated brush border proteins in relative stoichiometric amounts, as determined by densitometry and predicted tyrosine content. However, anti-C14p immunoprecipitated predominantly the 44-kDa polypeptide, suggesting that some of the protein is present dissociated from gp330 in the microvillar fraction. In addition, a 32-kDa protein was coprecipitated with C14p antiserum (Fig. 1, lane G) Ill, noprecipitations were prepared in parallel from radioiodinated brush border using antisera to a C14 fusion protein and a fusion protein containing the rat a2-MRAP sequence ( Fig.  2A, lanes 1 and 2) . Both antisera precipitate -450-and 44-kDa polypeptides with identical electrophoretic mobilities. To confirm that the antibodies are specific for the 44-kDa subunit, the gp330-44-kDa complex was purified on an anti-gp330 mAb 20B affinity column (Fig. 2B ) and subjected to Western blot analysis using C14p (Fig. 2C, lane 1) or rat a2-MRAP (Fig. 2C, lane 2) antiserum. Both antisera demonstrated immunoreactivity toward the 44-kDa polypeptide. Taken together, these data strongly suggest that the 44-kDa subunit shares immunological identity with C14p and a2-MRAP.
gp330 Forms a Stable Association with the 44-kDa Protein. Cosedimentation during velocity gradient centrifugation provides a qualitative assay of protein subunit assembly and oligomerization (18) . To verify and extend the immunoprecipitation data demonstrating the existence of a gp330-44-kDa complex, biosynthetically labeled baby rat kidney tissue was prepared, solubilized with Triton X-100, and fractionated on a 5-25% linear sucrose gradient. The resulting fractions were immunoprecipitated with anti-gp330 mAb 20B (Fig. 3) (Fig. 2B, lane 3) . gp330 also migrated more slowly under reducing conditions, indicating the presence of intrachain disulfide bridges (Fig. 2B, lane 2) . The identity of the 50-kDa protein that cosediments with the gp330-44-kDa complex is not known, but it may be an additional subunit of the multimeric complex. Immunocytochemical Lalization of C14p/azMRAP. By indirect immunofluorescence on acetone-fixed cryostat sections of rat kidney, the anti-Cl4p IgG labeled the brush border region of proximal tubules, in particular the basal region of the microvilli (Fig. 4A) . The pattern was similar to that seen with anti-gp330 IgG (5, 7) . Similar labeling was obtained with anti-a2-MRAP IgG (data not shown). In glomeruli a very faint diffuse granular labeling was obtained with anti-C14p IgG (Fig. SA) .
By contrast, in tissues fixed in PLP, the staining pattern obtained with anti-C14p IgG was very different. There was no staining of the brush border of proximal tubules; instead, a reticular, apical cytoplasmic immunofluorescence was seen (Fig. 4B) . By immunoelectron microscopy ( Fig. 4D) , diaminobenzidine reaction product was found only in the cisternae of the ER. Similar staining of the ER was also found in glomeruli (Fig. 5 B-D) . This suggests that the 44-kDa protein contains two or more epitopes, one that is demonstrable at the cell surface only in the native protein and another that is detectable in the rough ER primarily in fixed tissue. 
DISCUSSION
In this report, we have demonstrated that the HN antigen is represented within a multimeric complex consisting of two subunits-a large subunit with an apparent molecular mass that varies from 330 to 450 kDa (depending on the gel system) and a smaller, -44-kDa subunit. The larger polypeptide was previously identified as gp330, a glycoprotein present in coated pits of the kidney brush border and in the foot processes of glomerular podocytes (6, 7) . Our present data show that the 44-kDa subunit (i) is specifically recognized by antisera raised against a fusion protein encoded by the C14 cDNA sequence that was previously shown to contain a pathogenic epitope for HN (9) and (ii) shares immunological identity with a2-MRAP. Moreover, we have recently learned that the rat a2-MRAP sequence is identical to that of the C14 cDNA (J. Herz, M. S. Brown, and J. L. Goldstein, personal communication). Cl4p/a2-MRAP forms an association with gp330 that is stable to mild detergent extraction and long-term centrifugation, indicating a relatively high-affinity interac- tion. Pulse-chase experiments indicate that gp330 associates with the 44-kDa protein within minutes after its biosynthesis (unpublished data). a2-MRAP was originally discovered by its specific association with the a2-macroglobulin/LRP receptor (10) and more recently was shown to inhibit binding of a2-macroglobulin and apolipoprotein E/,8 very low density lipoprotein to the receptor (19) . The functional significance of the binding of this 44-kDa protein to gp330 is not yet known. Sequence analysis of partial cDNA clones for gp330 have revealed homologies to the cysteine-rich repeats of the LDL receptor (20) , suggesting that gp330 may be a member of the LDL receptor gene family that shares the 44-kDa protein as a common subunit (21) .
The physiological function of gp330 is currently unknown, but its localization in coated pits (6, 16, 22) suggests that it may serve as a cell surface receptor. Based on Western and ligand blot analysis, plasminogen has recently been identified as a potential ligand for gp330 (23) . In rat kidney proximal tubules, gp330 is found exclusively in coated pits located at the base of brush border microvilli (16) that are known to function in endocytosis (24, 25) . Immunoprecipitation studies performed on brush border membranes purified from the adult rat kidney demonstrate that the 44-kDa subunit may be present dissociated from gp330 in the proximal tubule and suggest that the 44-kDa protein may not have a requisite 1:1 stoichiometry with gp330. In addition, immunocytochemical results obtained on rat kidney tissue suggest that the 44-kDa protein is present at the cell surface and in the rough ER: anti-C14p IgG strongly labeled the basal (coated pit) region of proximal tubule microvilli in acetone-fixed cryostat sections, which is in keeping with the fact that when the anti-C14p IgG is injected in vivo it binds to the native HN antigenic complex located in the coated pits at the base of the foot processes (9) . By contrast, in aldehyde-fixed tissues labeling was confined to the ER in the proximal tubule and glomerular epithelium, suggesting that there is a significant pool of the protein in the ER. The localization of C14/a2-MRAP in the ER is in keeping with the fact that this protein contains a putative ER retention signal at its C terminus (10, 26) .
The initial events of HN are mediated by the binding of circulating antibodies to pathogenic epitopes located in clathrin-coated pits at the base of the foot processes of glomerular epithelial cells leading to the formation of immune deposits (7, 8) . Fig. 6 To determine which model best describes the mechanism of immune complex formation leading to glomerular injury, it will be necessary to obtain the full cDNA sequence for gp330 and study the pathogenicity of protein subdomains. In addition, structural information will be needed to establish whether heterodimer combinations between Cl4p/a2-MRAP 
